Literature DB >> 11226469

Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins.

E L Tham1, P L Jensen, M F Mescher.   

Abstract

T cell activation results from the engagement of multiple receptors on T cells by their respective ligands on antigen presenting cells. Studies using artificial cell surface constructs have demonstrated that effective T cell response requires that antigen be presented on a solid surface with dimensions that approximate those of an intact cell. In this report, we describe the cloning and expression of recombinant B7-1-Fc and B7-2-Fc proteins and their incorporation onto 5-microm latex microspheres along with renatured peptide-MHC. These microspheres provide a simple and effective method for the in vitro or in vivo stimulation of antigen-specific T cells under precisely controlled antigen and costimulation conditions.

Mesh:

Substances:

Year:  2001        PMID: 11226469     DOI: 10.1016/s0022-1759(00)00335-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

Review 1.  Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.

Authors:  Wenji Sun; Priyanka B Subrahmanyam; James E East; Tonya J Webb
Journal:  J Interferon Cytokine Res       Date:  2012-10-10       Impact factor: 2.607

Review 2.  Nanoscale artificial antigen presenting cells for cancer immunotherapy.

Authors:  Kelly R Rhodes; Jordan J Green
Journal:  Mol Immunol       Date:  2018-03-07       Impact factor: 4.407

Review 3.  Artificial antigen-presenting cells for use in adoptive immunotherapy.

Authors:  Cameron J Turtle; Stanley R Riddell
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

Review 4.  Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.

Authors:  Christian Schütz; Mathias Oelke; Jonathan P Schneck; Andreas Mackensen; Martin Fleck
Journal:  Immunotherapy       Date:  2010-07       Impact factor: 4.196

Review 5.  Engineering nano- and microparticles to tune immunity.

Authors:  James J Moon; Bonnie Huang; Darrell J Irvine
Journal:  Adv Mater       Date:  2012-05-29       Impact factor: 30.849

6.  Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.

Authors:  James E East; Wenji Sun; Tonya J Webb
Journal:  J Vis Exp       Date:  2012-12-29       Impact factor: 1.355

7.  Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function.

Authors:  Julie M Curtsinger; Debra C Lins; Matthew F Mescher
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

8.  Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.

Authors:  P Savage; P Cowburn; A Clayton; S Man; A McMichael; N Lemoine; A Epenetos; G Ogg
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

9.  Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation.

Authors:  Elana Ben-Akiva; Kelly R Rhodes; Randall A Meyer; Jordan J Green
Journal:  J Vis Exp       Date:  2018-10-12       Impact factor: 1.355

Review 10.  Linking form to function: Biophysical aspects of artificial antigen presenting cell design.

Authors:  Karlo Perica; Alyssa K Kosmides; Jonathan P Schneck
Journal:  Biochim Biophys Acta       Date:  2014-09-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.